# Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias

> **NCT04754399** · PHASE2 · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 40 (actual)

## Conditions studied

- Arthralgia
- Breast Cancer

## Interventions

- **DRUG:** Cannabidiol (CBD)

## Key facts

- **NCT ID:** NCT04754399
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-16
- **Primary completion:** 2023-10-10
- **Final completion:** 2023-10-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04754399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04754399, "Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04754399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*